DARMSTADT (DPA, CONVERSEER) – German pharmaceutical giant Merck has entered into an agreement with US President Donald Trump’s administration to broaden access to its in vitro fertilization (IVF) therapies. The initiative aims to support over 10 million American women facing fertility challenges, the company said on Thursday. Under the agreement, Merck’s US and Canadian healthcare division,...This article Pharma giant Merck announces US deal to cut IVF drug prices first appeared on Converseer.
Related Articles
Don't miss out on breaking stories and in-depth articles.